Leo M. Carlin

Leo M. Carlin

Auto-generated profile, based on publicly available information

Leo M. Carlin

Cancer Research UK Scotland Institute, Glasgow, UK

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Cell
Verified
Journal Article
Open access
LCLeo M. Carlin
Leo M. Carlin
ESEfstathios G. Stamatiades
Efstathios G. Stamatiades
CACedric Auffray
Cedric Auffray
RHRichard N. Hanna
Richard N. Hanna
LGLeanne Glover
Leanne Glover
FGFrederic Geissmann
Frederic Geissmann
The functions of Nr4a1-dependent Ly6C(low) monocytes remain enigmatic. We show that they are enriched within capillaries and scavenge microparticles from their lumenal side in a steady state. In the kidney cortex, perturbation of homeostasis by a TLR7-dependent nucleic acid "danger" signal, which may signify viral infection or local cell death, triggers Gαi-dependent intravascular retention of Ly6C(low) monocytes by the endothelium. Then, monocytes recruit neutrophils in a TLR7-dependent manner to mediate focal necrosis of endothelial cells, whereas the monocytes remove cellular debris. Prevention of Ly6C(low) monocyte development, crawling, or retention in Nr4a1(-/-), Itgal(-/-), and Tlr7(host-/-BM+/+) and Cx3cr1(-/-) mice, respectively, abolished neutrophil recruitment and endothelial killing. Prevention of neutrophil recruitment in Tlr7(host+/+BM-/-) mice or by neutrophil depletion also abolished endothelial cell necrosis. Therefore, Ly6C(low) monocytes are intravascular housekeepers that orchestrate the necrosis by neutrophils of endothelial cells that signal a local threat sensed via TLR7 followed by the in situ phagocytosis of cellular debris.

3 July 2011 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
RHRichard N Hanna
Richard N Hanna
LCLeo M Carlin
Leo M Carlin
HHHarper G Hubbeling
Harper G Hubbeling
DNDominika Nackiewicz
Dominika Nackiewicz
AGAngela M Green
Angela M Green
CHCatherine C Hedrick
Catherine C Hedrick

26 July 2018 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JRJoel S Riley
Joel S Riley
GQGiovanni Quarato
Giovanni Quarato
CCCatherine Cloix
Catherine Cloix
JLJonathan Lopez
Jonathan Lopez
JOJim O'PRey
Jim O'PRey
STStephen Wg Tait
Stephen Wg Tait
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 January 2018 in Cell Stem Cell
Verified
Journal Article
Open access
DDDelfim Duarte
Delfim Duarte
EHEdwin D. Hawkins
Edwin D. Hawkins
OAOlufolake Akinduro
Olufolake Akinduro
HAHeather Ang
Heather Ang
KFKatia De Filippo
Katia De Filippo
CCCristina Lo Celso
Cristina Lo Celso
Bone marrow vascular niches sustain hematopoietic stem cells (HSCs) and are drastically remodeled in leukemia to support pathological functions. Acute myeloid leukemia (AML) cells produce angiogenic factors, which likely contribute to this remodeling, but anti-angiogenic therapies do not improve AML patient outcomes. Using intravital microscopy, we found that AML progression leads to differential remodeling of vasculature in central and endosteal bone marrow regions. Endosteal AML cells produce pro-inflammatory and anti-angiogenic cytokines and gradually degrade endosteal endothelium, stromal cells, and osteoblastic cells, whereas central marrow remains vascularized and splenic vascular niches expand. Remodeled endosteal regions have reduced capacity to support non-leukemic HSCs, correlating with loss of normal hematopoiesis. Preserving endosteal endothelium with the small molecule deferoxamine or a genetic approach rescues HSCs loss, promotes chemotherapeutic efficacy, and enhances survival. These findings suggest that preventing degradation of the endosteal vasculature may improve current paradigms for treating AML.

17 April 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
STSim L. Tung
Sim L. Tung
DBDominic A. Boardman
Dominic A. Boardman
MSMonica Sen
Monica Sen
MLMarilena Letizia
Marilena Letizia
QPQi Peng
Qi Peng
LSLesley A. Smyth
Lesley A. Smyth
Regulatory T cells (Treg) are a subpopulation of T cells that maintain tolerance to self and limit other immune responses. They achieve this through different mechanisms including the release of extracellular vesicles (EVs) such as exosomes as shown by us, and others. One of the ways that Treg derived EVs inhibit target cells such as effector T cells is via the transfer of miRNA. Another key target for the immunoregulatory function of Tregs is the dendritic cells (DCs). In this study we demonstrate directly, and for the first time, that miRNAs are transferred from Tregs to DCs via Treg derived EVs. In particular two miRNAs, namely miR-150-5p and miR-142-3p, were increased in DCs following their interaction with Tregs and Treg derived exosomes. One of the consequences for DCs following the acquisition of miRNAs contained in Treg derived EVs was the induction of a tolerogenic phenotype in these cells, with increased IL-10 and decreased IL-6 production being observed following LPS stimulation. Altogether our findings provide data to support the idea that intercellular transfer of miRNAs via EVs may be a novel mechanism by which Tregs regulate DC function and could represent a mechanism to inhibit immune reactions in tissues.

10 July 2017 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
SRSteven E Reid
Steven E Reid
EKEmily J Kay
Emily J Kay
LNLisa J Neilson
Lisa J Neilson
AHAnne‐Theres Henze
Anne‐Theres Henze
JSJens Serneels
Jens Serneels
SZSara Zanivan
Sara Zanivan
Tumor progression alters the composition and physical properties of the extracellular matrix. Particularly, increased matrix stiffness has profound effects on tumor growth and metastasis. While endothelial cells are key players in cancer progression, the influence of tumor stiffness on the endothelium and the impact on metastasis is unknown. Through quantitative mass spectrometry, we find that the matricellular protein CCN1/CYR61 is highly regulated by stiffness in endothelial cells. We show that stiffness‐induced CCN1 activates β‐catenin nuclear translocation and signaling and that this contributes to upregulate N‐cadherin levels on the surface of the endothelium, in vitro . This facilitates N‐cadherin‐dependent cancer cell–endothelium interaction. Using intravital imaging, we show that knockout of Ccn1 in endothelial cells inhibits melanoma cancer cell binding to the blood vessels, a critical step in cancer cell transit through the vasculature to metastasize. Targeting stiffness‐induced changes in the vasculature, such as CCN1, is therefore a potential yet unappreciated mechanism to impair metastasis.